Abstract Purpose of Review Implementation of intensive LDL cholesterol (LDL-C) lowering
strategies and recognition of the role of triglyceride-rich lipoproteins (TRL) in atherosclerosis …

Low-density lipoprotein cholesterol is a well-known causal factor for atherosclerotic
cardiovascular disease, and is the primary target of lipid-lowering therapy. There is …

Background Genetic, observational, and clinical intervention studies indicate that circulating
levels of triglycerides and cholesterol transported in triglyceride-rich lipoproteins (remnant …

Aims Emerging evidence suggests that remnant cholesterol (RC) promotes atherosclerotic
cardiovascular disease (ASCVD). We aimed to estimate RC-related risk beyond low-density …

Background The atherogenicity of remnant cholesterol (RC) has been underlined by recent
guidelines, which was linked to coronary artery disease (CAD), especially for patients with …

Context Elevated serum remnant cholesterol independently predicts risks of cardiovascular
diseases. However, the association between remnant cholesterol and metabolic dysfunction …

Overall, data from observational studies in large cohorts, Mendelian randomization studies,
meta-regression analyses, and post-hoc analyses of randomized trials are consistent with …

Among the determinants of atherosclerotic cardiovascular disease (ASCVD), genetic and
experimental evidence has provided data on a major role of angiopoietin-like proteins 3 and …

Context Serum levels of remnant cholesterol have been reported to predict the prognosis of
cardiovascular disease, independent of traditional lipid profiles. Objective This study aimed …

Aims: This study aimed to investigate the association of elevated RC levels with adverse
cardiovascular outcomes in acute coronary syndrome (ACS) patients with and without …